NONOF News and Press, Novo-Nordisk A/S From 11/02/23

2023-11-02 02:41:41 ET More on Novo Nordisk: Novo Nordisk Milks The Obesity Cash Cow - How Long Will It Last? Novo Nordisk: Growing To Potentially Become The First Trillion-Dollar European Champion Novo Nordisk: DCF Analysis Suggests Significant Undervaluation ...

2023-10-26 09:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A historically wide di...

2023-10-26 08:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A historically wide di...

2023-10-20 09:04:17 ET More on Eli Lilly, Novo, etc. Eli Lilly: The GLP-1 Opportunity, While Increasingly Recognized, Is Vastly Underestimated Eli Lilly: Do Not Chase This Stock Over The Cliff Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase Eli...

2023-10-20 07:47:18 ET More on Eli Lilly Eli Lilly: The GLP-1 Opportunity, While Increasingly Recognized, Is Vastly Underestimated Eli Lilly: Do Not Chase This Stock Over The Cliff Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase Eli Lilly files...

2023-10-19 11:39:51 ET More on AbbVie, Eli Lilly, etc. AbbVie: The Humira Loss May Be Fully Priced In After All AbbVie: Q2 Success Sets The Stage For Consistent Growth AbbVie: Why You Should Pay Attention To This High-Yielding Dividend King (Rating Downgrade) ...

2023-10-19 09:01:05 ET More on GE HealthCare, Novo, etc. Novo Nordisk: DCF Analysis Suggests Significant Undervaluation Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Novo Nordisk: What The Stock Split Means For Traders And Investors Fake Ozem...

2023-10-19 01:20:00 ET Summary Baron Health Care Fund invests in companies engaged in the research, development, production, sale, delivery, or distribution of products and services related to the health care industry. The Fund trailed the Benchmark by 217 basis points this quarte...

2023-10-18 14:54:59 ET More on Novo Nordisk Novo Nordisk: DCF Analysis Suggests Significant Undervaluation Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Novo Nordisk: What The Stock Split Means For Traders And Investors Chart Talk: Did diabet...

2023-10-18 08:30:00 ET Summary Mawer Investment Management is a privately owned, independent investment firm, managing over $67B in assets for individual and institutional investors across all major asset classes. This quarter there was a divergence in the performance of holdings ...